Master protocol of two independent, randomized, double-blind, Phase 3 studies comparing efficacy and safety of frexalimab (SAR441344) to teriflunomide in adult participants with relapsing forms of multiple sclerosis

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

Brain Imaging Center - BIC
Department Specific Free Standing Clinic
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Enrique Alvarez

Enrique Alvarez

Study ID

Protocol Number: 23-2277

More information available at ClinicalTrials.gov: NCT06141473

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers